Astex Pharmaceuticals, Inc.
299 articles with Astex Pharmaceuticals, Inc.
-
Astex Pharmaceuticals Responds to Further Misleading Claims Made by Sarissa Capital
10/10/2013
-
Astex Pharmaceuticals Announces Expiration of HSR Waiting Period for Pending Transaction
10/7/2013
-
Astex Pharmaceuticals Shareholder Opposes $886 Million Bid by Otsuka Pharmaceutical Co., Ltd.
10/3/2013
-
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 AML Data at the European Cancer Congress
9/30/2013
-
Japan's Otsuka Pharmaceutical Co., Ltd. Shells Out $886 Million for U.S. Cancer Firm Astex Pharmaceuticals
9/5/2013
-
Astex Pharmaceuticals to Present at Investor Conferences in September
9/3/2013
-
Astex Pharmaceuticals Sees Positive Results From SGI-110 AML Phase 2 Study; Stock Rockets +24.45% at Market Close (August 28, 2013)
8/28/2013
-
Astex Pharmaceuticals Reports 2013 Second Quarter Financial Results
8/1/2013
-
Astex Pharmaceuticals to Announce 2013 Second Quarter Financial Results on August 1st
7/29/2013
-
Astex Pharmaceuticals Announces First Data Showing Early Combination Treatment of HSP90 Inhibitor AT13387 With Targeted Agents Delays Emergence of Resistance in Preclinical Models
7/22/2013
-
Astex Pharmaceuticals Announces IND Candidate: ASTX727 a Potential Best-in-Class Oral Hypomethylator
7/8/2013
-
Astex Pharmaceuticals to Present at JMP Securities Healthcare Conference
7/3/2013
-
Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO)
6/20/2013
-
Astex Pharmaceuticals to Present at Jefferies and Co. Global Healthcare Conference
5/29/2013
-
Astex Pharmaceuticals to Present at UBS Global Healthcare Conference
5/14/2013
-
Astex Pharmaceuticals to Present at Needham Healthcare Conference
4/23/2013
-
Astex Pharmaceuticals to Present at ROTH Conference
3/12/2013
-
Astex Pharmaceuticals Release: Cancer Research Technology and Cancer Research UK Cambridge Research Institute Initiate AT13148 Clinical Trial to Treat Several Cancer Types
1/17/2013
-
Astex Pharmaceuticals to Present at Biotech Showcase 2013
1/3/2013
-
Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients
1/2/2013